期刊文献+

MyD88、TLR4和STAT3在肝细胞癌组织中的表达及意义 被引量:7

Expression and significance of MyD88,TLR4 and STAT3 in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨TLR4、MyD88、STAT3在肝细胞癌组织中的表达及生物学意义。方法采用免疫组化方法检测TLR4、MyD88、STAT3在82例肝癌组织及其对应的癌旁肝组织中的表达水平。结合肝癌临床病理指标分析相关性。结果 TLR4、MyD88、STAT3蛋白在癌组织中的阳性表达率为76.8%(63/82)、67.1%(55/82)、69.5%(57/82),高于在癌旁肝组织中的阳性表达率25.9%(12/82)、12%(9/82)、8.5%(7/82),差异均具有统计学意义(P<0.05);在肝癌组织中TLR4、MyD88、STAT3的阳性表达呈正相关[TLR4和MyD88(r=0.612,P=0.011),MyD88和STAT3(r=0.578,P=0.002),TLR4和STAT3(r=0.542,P=0.016)]。MyD88和STAT3表达与性别、分化程度、有无HBV感染和肝硬化有关(P<0.05),而与肿瘤大小、有无静脉浸润无关(P>0.05)。结论 TLR4、MyD88、STAT3表达上调,导致肝癌细胞增殖和免疫逃逸是肝癌发生发展的重要分子机制。 【Objective】 To investigate the expression and significance of TLR4,MyD88 and STAT3 in hepatocellular carcinoma.【Methods】 S-P immunohistological assay was applied to detect the expression of TLR4,MyD88 and STAT3 genes in hepatocellular carcinoma tissues and adjacent normal tissues of 82 cases.Correlation analysis was used to determine the relation of TLR4,MyD88 and STAT3 with clinicopathological data.【Results】 The positive rates of TLR4,MyD88 and STAT3 expression were 76.8%(63/82),67.1%(55/82) and 69.5%(57/82) in 82 hepatocellular carcinoma tissues,which were significantly higher than those(25.9 %,12% and 8.5 %) in adjacent normal tissues(P〈0.05).TLR4 expression was positively correlated with MyD88(r =0.612,P =0.011) and STAT3(r =0.542,P =0.016),MyD88 and STAT3 expression was also positively correlated(r =0.578,P =0.002).The expression of MyD88 and STAT3 in HCC was in significant relation to gender,age,pathological grade,HBV infection and liver cirrhosis(P〈0.05),but not significantly related to tumor size or venous infiltration(P〈0.05).【Conclusions】 TLR4,MyD88 and STAT3 proteins are significantly over-expressed in HCC tissues.The over-expression results in cell proliferation and immune escape which promote the initiation and development of HCC.
作者 厉鸥 王方明
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第9期1089-1094,共6页 China Journal of Modern Medicine
关键词 肝细胞癌 TLR4 MYD88 STAT3 免疫逃逸 hepatocellular carcinoma TLR4 MyD88 STAT3 immune escape
  • 相关文献

参考文献1

二级参考文献3

共引文献13

同被引文献51

  • 1曾治民,何静,刘安文.Toll样受体信号传导与炎症相关肿瘤的关系[J].中国癌症杂志,2011,21(6):489-494. 被引量:17
  • 2杨一新,李桂源.LPS所介导的信号转导通路研究进展[J].中南大学学报(医学版),2006,31(1):141-145. 被引量:49
  • 3Pikarsky E, Porat RM, Stein I, et al. NF - kappaB functions as a tumour promoter in inflammation - asso- ciated cancer [ J ]. Nature, 2004,431 (7007) :461.
  • 4Marx J. Cancer research. Inflammation and cancer:The link grows stronger [ J ]. Science, 2004, 306 (5698) :966.
  • 5Hennessy EJ, Parker AE, ONeill LA. Targeting Toll - like receptors: emerging therapeutics [ J ]. Nat Rev Drug Discov ,2010,9 (4) : 293 - 307.
  • 6Ekihiro Seki, Eek Joong Park, Jiro Fujimoto. Toll - like receptor signaling in liver regeneration, fibrosis and carcinogenesis [ J ]. Hepatology Research, 2011, 41:597 -610.
  • 7Okamoto T, Sanda T, Asamitsu K, NF - kappa B sig- naling and carcinogenesis [ J ]. Curr Pharm Des 2007, 13,447 - 462.
  • 8Zhang L,Han J , Wu H, et al. The association of HMGB1 ex-pression with clinicopathological significance and prognosis inhepatocellular carcinoma: a meta-analysis and literature review[J]. PLoS One, 2014, 9C10) :el 10626.
  • 9Qu L,Wang Y,Gong L,et al. Suicide gene therapy for hepato-cellular carcinoma cells by survivin promoter-driven expressionof the herpes simplex virus thymidine kinase gene[J], OncolRep, 2013’ 29(4):1435-1440.
  • 10Li PM, Li YL, Liu B,et al. Curcumin inhibits MHCC97H livercancer cells by activating ROS/TLR-4/caspase signaling path-way[J], Asian Pac J Cancer Prev, 2014,15(5) : 2329-2334.

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部